Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease SANTA ...
A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather in Paris for this year’s EuroPCR. Intravascular lithotripsy (IVL) has become ...
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools PARIS, May 20, 2025 ...
SAN FRANCISCO, CA—The use of cutting and noncompliant balloons for lesion preparation appears to provide results similar to those achieved with Shockwave intravascular lithotripsy (IVL; Shockwave ...
Johnson & Johnson is moving to expand its position in cardiovascular intervention with the acquisition of California-based Shockwave Medical Inc. J&J and the target announced a definitive agreement ...
Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions Technology has received U.S. FDA ...
NEW BRUNSWICK, N.J. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a ...
Johnson & Johnson acquired medtech company Shockwave Medical for $13.1 billion, the pharma giant announced Friday morning. The deal, which has been approved by the board of directors of both companies ...
Johnson & Johnson shocked the medtech industry early last year when it announced it would acquire Shockwave Medical, a specialist in the intravascular lithotripsy (IVL) market. Shockwave had a huge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results